ArticleInternational journal of ophthalmology2026
Management of polypoidal choroidal vasculopathy: Malaysian Consensus Guideline 2023.
Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim for this study was to develop consensus terminology, diagnostic criteria of multimodal imaging and develop a guideline for management of polypoidal choroidal vasculopathy (PCV). A systematic consensus process was conducted to develop updated clinical recommendations for the management of PCV. In order to develop the guidelines, a panel of ten PCV experts nationwide reviewed current evidence, focusing on key randomized controlled trials (EVEREST-II and PLANET), and conducted a systematic literature search to inform the guidelines. Several draft recommendations were evaluated and improved to determine the strength and quality of evidence. Consensus was defined as ≥90% agreement achieved, with multiple voting rounds if needed. The finalized guidelines incorporate the most recent evidence available up to November 30, 2023. The panelists reached an agreement on several aspects of PCV management, including the need for diagnostic criteria, classification, various treatment options and the development of a treatment algorithm. Recommendations are made for the clinical management of PCV based on a professional assessment of current evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.